Report

Global Autoinjectors Market Size study, by Type (Disposable Autoinjectors, Reusable Autoinjectors), by Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Others), by End-User (Home Care Settings, Hospitals & Clinics) and Regional Forecasts 2020-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Autoinjectors Market, by Region, 2018-2027 (USD Billion)
1.2.2. Autoinjectors Market, by Type, 2018-2027 (USD Billion)
1.2.3. Autoinjectors Market, by Application, 2018-2027 (USD Billion)
1.2.4. Autoinjectors Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Autoinjectors Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Autoinjectors Market Dynamics
3.1. Autoinjectors Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Autoinjectors Market: Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Autoinjectors Market, by Type
5.1. Market Snapshot
5.2. Global Autoinjectors Market by Type, Performance - Potential Analysis
5.3. Global Autoinjectors Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4. Autoinjectors Market, Sub Segment Analysis
5.4.1. Disposable Autoinjectors
5.4.2. Reusable Autoinjectors
Chapter 6. Global Autoinjectors Market, by Application
6.1. Market Snapshot
6.2. Global Autoinjectors Market by Application, Performance - Potential Analysis
6.3. Global Autoinjectors Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Autoinjectors Market, Sub Segment Analysis
6.4.1. Rheumatoid Arthritis
6.4.2. Anaphylaxis
6.4.3. Multiple Sclerosis
6.4.4. Others
Chapter 7. Global Autoinjectors Market, by End-User
7.1. Market Snapshot
7.2. Global Autoinjectors Market by End-User - Potential Analysis
7.3. Global Autoinjectors Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
7.4. Autoinjectors Market, Sub Segment Analysis
7.4.1. Home Care Settings
7.4.2. Hospitals & Clinics
Chapter 8. Global Autoinjectors Market, Regional Analysis
8.1. Autoinjectors Market, Regional Market Snapshot
8.2. North America Autoinjectors Market
8.2.1. U.S. Autoinjectors Market
8.2.1.1. Type breakdown estimates & forecasts, 2017-2027
8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
8.2.1.3. End-User breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Autoinjectors Market
8.3. Europe Autoinjectors Market Snapshot
8.3.1. U.K. Autoinjectors Market
8.3.2. Germany Autoinjectors Market
8.3.3. France Autoinjectors Market
8.3.4. Spain Autoinjectors Market
8.3.5. Italy Autoinjectors Market
8.3.6. Rest of Europe Autoinjectors Market
8.4. Asia-Pacific Autoinjectors Market Snapshot
8.4.1. China Autoinjectors Market
8.4.2. India Autoinjectors Market
8.4.3. Japan Autoinjectors Market
8.4.4. Australia Autoinjectors Market
8.4.5. South Korea Autoinjectors Market
8.4.6. Rest of Asia Pacific Autoinjectors Market
8.5. Latin America Autoinjectors Market Snapshot
8.5.1. Brazil Autoinjectors Market
8.5.2. Mexico Autoinjectors Market
8.6. Rest of The World Autoinjectors Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Amgen Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Antares Pharma, Inc.
9.2.3. Becton Dickinson and Company
9.2.4. Eli Lilly and Company
9.2.5. Johnson and Johnson
9.2.6. Mylan N.V.
9.2.7. Novartis AG
9.2.8. SHL Medical
9.2.9. Teva Pharmaceutical Industries Ltd
9.2.10. Ypsomed AG
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption